334 results on '"Serrano, Davide"'
Search Results
52. Response to Braillon
53. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer
54. Breast Cancer Prevention Trials Using Retinoids
55. Quality of life assessment in a chemoprevention trial: Fenretinide and oral or transdermal HRT
56. Abstract 1705: Identification of an immune gene expression signature for progression of breast ductal carcinoma in situ (dcis)
57. Relationship between CYP2D6 genotype, tamoxifen metabolites, and adverse events, tumor biomarkers and breast cancer recurrence in a low-dose phase III trial in noninvasive disease.
58. Abstract PD3-08: Effects of low dose tamoxifen on circulating risk biomarkers in a phase III trial in breast pre-invasive disease
59. Abstract OT1-04-03: Alternative dosing of exemestane before surgery in postmenopausal patients with stage 0-II estrogen receptor positive breast cancer: Design and methodology
60. A 15-Year Follow-up of AJCC Stage III Malignant Melanoma Patients Treated Postsurgically with Newcastle Disease Virus (NDV) Oncolysate and Determination of Alterations in the CD8 T Cell Repertoire
61. Prevention of breast cancer
62. Preliminary Results on Safety and Activity of a Randomized, Double-Blind, 2 × 2 Trial of Low-Dose Tamoxifen and Fenretinide for Breast Cancer Prevention in Premenopausal Women
63. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer
64. Author Correction:Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation (Nature Medicine, (2019), 25, 4, (667-678), 10.1038/s41591-019-0405-7)
65. Anti-HIV effects of chloroquine: mechanisms of inhibition and spectrum of activity
66. Pharmacological prevention of breast cancer: Quo Vadis?
67. Breast ductal lavage for biomarker assessment in high risk women: rationale, design and methodology of a randomized phase II clinical trial with nimesulide, simvastatin and placebo
68. Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia
69. WITHDRAWAL—Administrative Duplicate Publication: The essential role of prevention in reducing the cancer burden in Europe: a commentary from Cancer Prevention Europe
70. Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancer
71. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer
72. Therapeutic cancer prevention: achievements and ongoing challenges – a focus on breast and colorectal cancer
73. Quality of Life in a Randomized Breast Cancer Prevention Trial of Low-Dose Tamoxifen and Fenretinide in Premenopausal Women
74. Characterization of the T Cell Receptor Repertoire in Patients with Common Variable Immunodeficiency: Oligoclonal Expansion of CD8+ T Cells
75. Abstract 248: Association of vitamin D related polymorphisms with hereditary breast cancer in 431 patients wild type for BRCA1 and BRCA2 mutations
76. Hereditary diffuse gastric cancer in two families: A case report
77. A Presurgical Study of Lecithin Formulation of Green Tea Extract in Women with Early Breast Cancer
78. Association of baseline plasma levels of 25OH vitamin D and breast cancer risk in a chemoprevention trial.
79. Prognostic impact of genetic variants of CYP19A1and UGT2B17in a randomized trial for endocrine-responsive postmenopausal breast cancer
80. Benefit of low-dose tamoxifen in a large observational cohort of high risk ER positive breast DCIS
81. Abstract CT122: A presurgical study of lecithin formulation of green tea extract in women with early breast cancer
82. Abstract 1788: Benefit of low-dose tamoxifen in a large, single-institution cohort of high-risk ER-positive DCIS
83. A Randomized, Placebo-Controlled, Phase II, Presurgical Biomarker Trial of Celecoxib Versus Exemestane in Postmenopausal Breast Cancer Patients
84. A Presurgical Study of Oral Silybin-Phosphatidylcholine in Patients with Early Breast Cancer
85. A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users: the HOT study
86. Abstract A39: Meta-analysis on vitamin D Receptor polymorphisms and colorectal cancer risk
87. Effect of Metformin on Breast Ductal Carcinoma In Situ Proliferation in a Randomized Presurgical Trial
88. Abstract 1909: Associations of Vitamin D related polymorphisms with hereditary breast cancer in 1025 subjects undergoing BRCA 1/2 testing
89. Abstract P3-06-43: A genetic deletion in the uridine diphosphate glucuronosyltransferase 2B17 affects the pharmacokinetics of exemestane
90. Abstract P5-12-02: Metformin decreases Ki67 in HER2+ve ductal carcinoma in situ in a window of opportunity trial
91. Cancer chemoprevention: Much has been done, but there is still much to do. State of the art and possible new approaches
92. WITHDRAWAL—Administrative Duplicate Publication: The essential role of prevention in reducing the cancer burden in Europe: a commentary from Cancer Prevention Europe
93. BsmI polymorphism of vitamin D receptor gene and cancer risk: A comprehensive meta-analysis
94. Vitamin D receptor polymorphismFokIand cancer risk: a comprehensive meta-analysis
95. Differential effects of metformin on breast cancer proliferation according to insulin resistance and tumor subtype in a presurgical trial.
96. A presurgical study of oral silybin-phosphatidylcholine in patients with early breast cancer.
97. Complementary molecular approaches reveal heterogeneous CDH1 germline defects in Italian patients with hereditary diffuse gastric cancer (HDGC) syndrome
98. A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer
99. Metformin effects on cancer adjacent breast preneoplasia in a randomized pre-surgical trial.
100. Abstract 167: A comparison of 25-OH-vitamin D levels and VDR polymorphisms in healthy and patients with breast intraepithelial neoplasia or cancer .
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.